Abbott Receives FDA Emergency Use Authorization and Launches Test to Detect Novel Coronavirus
Abbott announced today that the U.S. Food and Drug Administration has issued Emergency Use Authorization (EUA) for the company's molecular ...
Tag: Magazine Edition 24 March 2020
These articles also appear in the Global Biodefense Magazine – 24 March 2020 edition.
Serological Assay to Detect SARS-CoV-2 Seroconversion in Humans
We currently lack serological assays suitable to specifically detect SARS-CoV-2 antibodies, of critical importance to determine seroprevalence in a given ...
Regeneron Makes Progress on Novel COVID-19 Antibody Program
Regeneron Pharmaceuticals, Inc. today announced the latest progress in its efforts to discover and develop a novel multi-antibody cocktail that ...
The Proximal Origin of SARS-CoV-2
Identifying the closest viral relatives of SARS-CoV-2 circulating in animals will greatly assist studies of viral function. The genomic features ...
New Coronavirus SARS-CoV-2 Stable for Hours to Days on Surfaces
The virus that causes coronavirus disease 2019 (COVID-19) is stable for several hours to days in aerosols and on surfaces, ...
PharmaJet Receives $9.6 Million Dollar Award to Support Next-Generation Needle-Free Delivery Devices
PharmaJet has announced that it received a $9.6 million dollar contract award from the Joint Science and Technology Office of ...
Novel High-Density Microarray Patch Can Deliver Vaccines Directly to the Skin
Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced the publication in the journal PLoS Medicine of ...
FDA Policy Change Clears Path for Wider Use of Co-Diagnostics’ Coronavirus Test
Molecular diagnostics company Co-Diagnostics, Inc. announced today that a new FDA policy released last night aimed at expediting the availability ...
Hotel Influenza: Research Heats Up on Universal Flu Vaccines
A universal flu vaccine has eluded scientists for decades. Unlike other viruses, influenza has a rapid-fire mutation rate and thousands ...
Pfizer and BioNTech to Co-Develop Potential COVID-19 Vaccine
Companies will jointly develop BioNTech’s mRNA-based vaccine candidate BNT162 to prevent COVID-19 infection. Pfizer Inc. and BioNTech SE today announced ...
FDA Pandemic Response: States Can Now Approve COVID-19 Diagnostics, Serology Testing
The FDA today took unprecedented measures to expand coronavirus disease 2019 (COVID-19) diagnostics testing capacity by modifying policy originally issued on Feb. ...
Free Coronavirus Sequencing Kits for Researchers Offered by U-M Startup
As doctors, scientists and governments try to get a grip on COVID-19, the University of Michigan startup Arbor Biosciences is ...
Operation 50/50: List of Women Health Security Experts Now Available
Women in Global Health (WGH), and Women of Color Advancing Peace and Security (WCAPS) have partnered to crowdsource a list ...
BD, BioGX Announce FDA EUA Submissions for New COVID-19 Diagnostics
BD and BioGX Inc today announced that the companies have submitted Emergency Use Authorization requests to the U.S. Food and ...
Regeneron and Sanofi Begin Global Clinical Trial for Use of Sarilumab in Severe COVID-19 Patients
U.S. Phase 2/3 trial initiated and will begin enrolling patients immediately Regeneron is leading U.S. trials, Sanofi will lead upcoming ex-U.S. trials Regeneron Pharmaceuticals, ...
What Lessons Can the US Learn from Japan and South Korea for Combating Coronavirus?
On January 20, the World Health Organization (WHO) declared the spread of COVID-19, the disease caused by the new coronavirus ...
Moderna Announces First Participant Dosed in Phase 1 Study of mRNA Coronavirus Vaccine
Moderna, Inc. a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines today announced that the first participant ...
Caught Flat-Footed: How the U.S. Can Now Rally a Response Against Coronavirus
It’s always been a question of when, and not whether, humanity would face another challenge on the scale of the ...
LJI Scientists Identify Potential Targets for Immune Responses to SARS-CoV-2
Within two months, SARS-CoV-2, a previously unknown coronavirus, has raced around globe, infecting over a 100,000 people with numbers continuing ...
COVID-19 and Italy: What Next?
There is now grave concern regarding the Italian national health system's capacity to effectively respond to the needs of patients ...
